Lithium hydroxide

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Lithium hydroxide
Accession Number
DB14506
Description

Used for tryptophan determinations in proteins & foods.

Type
Small Molecule
Groups
Approved, Withdrawn
Structure
Thumb
Weight
Average: 23.95
Monoisotopic: 24.01874309
Chemical Formula
HLiO
Synonyms
  • Lithium hydrate
  • Lithium hydroxide anhydrous
  • Lithiumhydroxid

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbacavirAbacavir may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AcarboseAcarbose may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AceclofenacAceclofenac may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AcemetacinAcemetacin may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AcetaminophenAcetaminophen may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AcetazolamideThe absorption of Lithium hydroxide can be decreased when combined with Acetazolamide.
AcetophenazineLithium hydroxide may increase the neurotoxic activities of Acetophenazine.
Acetylsalicylic acidAcetylsalicylic acid may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AclidiniumAclidinium may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
AcrivastineAcrivastine may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

Products

Product Ingredients
IngredientUNIICASInChI Key
Lithium hydroxide monohydrateG51XLP968G1310-66-3GLXDVVHUTZTUQK-UHFFFAOYSA-M
Active Moieties
NameKindUNIICASInChI Key
Lithium cationionic8H8Z5UER667439-93-2HBBGRARXTFLTSG-UHFFFAOYSA-N
Generic Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Lithium Hydroxide MonohydrateSolution8 meq/5mLOralMorton Grove Pharmaceuticals, Inc.1986-05-212011-04-06Us
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
903YL31JAS
CAS number
1310-65-2
InChI Key
WMFOQBRAJBCJND-UHFFFAOYSA-M
InChI
InChI=1S/Li.H2O/h;1H2/q+1;/p-1
IUPAC Name
lithium(1+) hydroxide
SMILES
[Li+].[OH-]

References

General References
Not Available
ChemSpider
3802
RxNav
1546375
ChEBI
33979
Wikipedia
Lithium_hydroxide

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
SolutionOral8 meq/5mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP0ChemAxon
pKa (Strongest Acidic)3.09ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity0 m3·mol-1ChemAxon
Polarizability1.78 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on July 11, 2018 15:53 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates